Lamivudine Tablet, Film Coated
Product Images NDC 33342-002

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 33342-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Lamivudine Fig 1)

FDA Label Image

Str (Lamivudine Str)

FDA Label Image

150-60s (Lamivudine Tab 150mg 60s)

Lamivudine tablets are available in 150 mg dosage and manufactured by Macleods Pharma USA, Inc. The usual dosage instructions can be found in the prescribing information for Lamivudine USP. It contains 60 tablets and should be stored at a temperature of 20° to 25°C with excursions permitted between 15° to 30°C. The tablets are manufactured by Macleods Pharmaceuticals Ltd. in Daman, India with the code number DD/DRUGS/DD/375.*

FDA Label Image

300mg-30s (Lamivudine Tab 300mg 30s)

Lamivudine USP 300 mg is a medication available in tablet form with NDC 33342-002-07 code. The usual dosage of Lamivudine is mentioned in the prescribing information. The tablets should be stored at a temperature of 20° to 25°C (68° to 77° F), while some excursions are allowed at 15° to 30° C (59° to 86° F). Macleods Pharma USA, Inc. is the manufacturer of this medication, with Macleods Pharmaceuticals Ltd. being the manufacturer, located in Daman (U.T.), INDIA with code No.: DD/DRUGS/DD/375. Only 30 tablets of this medication are available per pack.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.